Effects of SRX246, a Vasopressin Receptor (V1a) Antagonist, on an Experimental Model of Phasic and Sustained Threat in Humans

BIOLOGICAL PSYCHIATRY(2019)

引用 1|浏览17
暂无评分
关键词
Vasopressin 1a Receptor Antagonist,Startle,Anxiety & PTSD,Phase II Clinical Trial,Threat of Shock
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要